Literature DB >> 11572470

Review: practical issues in intravitreal drug delivery.

D Maurice1.   

Abstract

The delivery of drugs to the retina from solution or from prolonged release forms is considered in terms of pharmacokinetics, interference with vision, and toxicity and safety. It is concluded that visual loss will be the limiting factor in determining the useful life of a drug administered as a microdispersion. Because microparticles can be lost from the vitreous by diffusion, a condensed depot of drug can give a greater lifetime. However, it needs to be anchored outside the visual pathway which requires an intraocular operative procedure. Attaching a reservoir to the external sclera with a diffusion-controlled entry through a tube to the vitreous is suggested as having more flexibility than other systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572470     DOI: 10.1089/108076801753162807

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  28 in total

1.  Hydraulic flow and vascular clearance influences on intravitreal drug delivery.

Authors:  Paul J Missel
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  Ocular pharmacokinetic study of a corticosteroid by 19F MR.

Authors:  Xin Liu; S Kevin Li; Eun-Kee Jeong
Journal:  Exp Eye Res       Date:  2010-06-09       Impact factor: 3.467

3.  Solution formulation development of a VEGF inhibitor for intravitreal injection.

Authors:  Michelle T Marra; Penney Khamphavong; Peter Wisniecki; Hovhannes J Gukasyan; Katsuhiko Sueda
Journal:  AAPS PharmSciTech       Date:  2011-02-11       Impact factor: 3.246

4.  MRI study of subconjunctival and intravitreal injections.

Authors:  S Kevin Li; Jinsong Hao; Hongshan Liu; Jing-huei Lee
Journal:  J Pharm Sci       Date:  2012-03-30       Impact factor: 3.534

Review 5.  A comprehensive insight on ocular pharmacokinetics.

Authors:  Vibhuti Agrahari; Abhirup Mandal; Vivek Agrahari; Hoang M Trinh; Mary Joseph; Animikh Ray; Hicheme Hadji; Ranjana Mitra; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

6.  Novel nanoparticulate gel formulations of steroids for the treatment of macular edema.

Authors:  Sai H S Boddu; Jwala Jwala; Ravi Vaishya; Ravinder Earla; Pradeep K Karla; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2010-02       Impact factor: 2.671

7.  Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

Authors:  Eda I Altiok; Jorge L Santiago-Ortiz; Felicia L Svedlund; Aline Zbinden; Amit K Jha; Deepika Bhatnagar; Peter Loskill; Wesley M Jackson; David V Schaffer; Kevin E Healy
Journal:  Biomaterials       Date:  2016-03-12       Impact factor: 12.479

8.  Influence of dosage form on the intravitreal pharmacokinetics of diclofenac.

Authors:  Chandrasekar Durairaj; Stephen J Kim; Henry F Edelhauser; Jaymin C Shah; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-10       Impact factor: 4.799

9.  Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.

Authors:  Liang Feng; S Kevin Li; Hongshan Liu; Chia-Yang Liu; Kathleen LaSance; Farzin Haque; Dan Shu; Peixuan Guo
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

10.  Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs.

Authors:  Seong Joon Ahn; Hye Kyoung Hong; Young Mi Na; Sang Jun Park; Jeeyun Ahn; Jaeseong Oh; Jae Yong Chung; Kyu Hyung Park; Se Joon Woo
Journal:  J Vis Exp       Date:  2016-07-23       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.